MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
Titel:
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
Auteur:
Hong, David S Hui, David Bruera, Eduardo Janku, Filip Naing, Aung Falchook, Gerald S Piha-Paul, Sarina Wheler, Jennifer J Fu, Siqing Tsimberidou, Apostolia M Stecher, Michael Mohanty, Prasant Simard, John Kurzrock, Razelle